Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BI Shanghai Renews Pact With Sinopharm To Quadruple China Sales

This article was originally published in PharmAsia News

Executive Summary

Boehringer Ingelheim's China arm renewed its lucrative distribution agreement with Sinopharm Medicine Holding. Boehringer Ingelheim Shanghai Pharmaceuticals said its Chinese sales are expected to more than quadruple in the period between 2006, the year before the agreement was initiated, and 2012. In 2007, BI Shanghai signed a one-year agreement giving Sinopharm its first distribution deal with a foreign company, while making BI the first foreign drug maker to give a Chinese company full distribution rights for all of its products. The renewal extends the agreement through the end of 2009. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068071

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel